Chilivis Grubman LLP
  • Home
  • Firm Overview
  • Attorneys
    • Scott R. Grubman
    • Lauren A. Warner
    • Jeremy T. Berry
    • Brittany M. Cambre
    • Joseph J. Siegelman
    • Hakim Hilliard
    • Sanjay Karnik
    • Brandi Z. Murrain
    • Maiysha Rashad
  • Practice Areas
    • Healthcare
      • Government Investigations & Litigation
      • Payor Audits and Audit Appeals
      • HIPAA and Cybersecurity
      • Medical Board Investigations
      • Peer Review & Credentialing Disputes
      • Healthcare Regulatory Compliance
    • Civil and Business Litigation
      • Class Action Defense
    • Criminal Defense
      • White Collar Crime
      • Healthcare Fraud
      • Public Corruption
      • Internal Investigations
    • False Claims Act and Qui Tam Defense
    • Data Privacy & Cybersecurity
    • Internal Investigations
    • Government Affairs
      • Advocacy and Regulatory Affairs
      • Government Contracts
      • Government Litigation and Administrative Law
      • Advertising Compliance
      • Land Use & Zoning
      • Licensing and Permits
    • Campaign Finance and Election Law
    • Entertainment Law & Artist Management
      • Trademark, Copyright, and Brand Protection
  • Blog
  • News
  • Insights
  • Contact
Select Page

Profiteering Relators Beware: Courts Upholds Dismissal of Opportunistic Qui Tam Action

Oct 12, 2020 | False Claims Act

The False Claims Act (“FCA”) was enacted in 1863 as a tool to deter fraud against the government. The FCA prohibits presenting to the government a false or fraudulent claim for payment or approval. Congress strengthened the FCA in 1986 when it amended the qui tam...

DOJ Announces Record-Breaking Healthcare Takedown Involving 345 Defendants and $6 Billion in Alleged Fraud Losses

Oct 6, 2020 | False Claims Act, Government Investigations

On September 30, 2020, the U.S. Department of Justice (“DOJ”) issued a press release regarding a nationwide enforcement action involving 345 defendants allegedly responsible for submitting more than $6 billion in fraudulent healthcare claims.  According to the DOJ,...

DOJ Issues Guidance On Inability To Pay Process

Sep 11, 2020 | False Claims Act, Government Investigations

Even throughout the COVID-19 pandemic, the federal False Claims Act (FCA) has remained one of the federal government’s top tools to investigate and punish alleged fraud, waste, and abuse in relation to federal programs, particularly federal healthcare programs.  In...

Recent Ruling: Georgia Taxpayer Protection False Claims Act

Aug 31, 2020 | False Claims Act

The Georgia Court of Appeals recently ruled on a case involving interpretation of the Georgia Taxpayer Protection False Claims Act (“TPFCA”), O.C.G.A. §23-3-120, et seq., which has not been the subject of many court opinions.  The TPFCA authorizes the State of Georgia...

Multi-Million Dollar Kickback Settlements Continue Despite Covid-19

Aug 31, 2020 | False Claims Act, Fraud Investigations, Government Investigations, Health Care, Medicare and Medicaid, White Collar Crime

The federal Anti-Kickback Statute (AKS), at its core, prohibits offering, paying, soliciting, or receiving any remuneration in exchange for federal healthcare program referrals.  AKS violations carry potential criminal penalties, as well as civil and administrative...

Senator Grassley Proposes Legislation To Strengthen False Claims Act

Aug 4, 2020 | False Claims Act, Government Investigations

On July 30, 2020, United States Senator Charles Grassley announced that he intends to introduce legislation which would strengthen the federal False Claims Act (FCA).  Grassley indicated that his proposed legislation would, at least in part, specifically address the...
« Older Entries
Next Entries »

Recent Posts

  • Little Caesar’s Completes Seventh Circuit Sweep in Trademark Challenge to “Pizza Puff” Products.
  • With Bivens on Life Support, FTCA May Be Viable Option for Claims Against ICE
  • Does the ICE Agent Who Killed Renee Good Really Have Immunity?
  • False Claims Act Recoveries Exceed $6.8B in FY2025; Highest Ever
  • Kaiser Agrees to $556 Million False Claims Act Settlement

Categories

  • A.I. Law
  • Accessory Dwelling Units
  • Administrative Law
  • Anti-Counterfeit
  • Atlanta News
  • Brand Protection
  • Business Litigation
  • Civil Healthcare Litigation
  • Civil Matters
  • Civil Rights
  • Code Enforcement
  • Commercial Litigation
  • Commercial Payor Audits
  • Complex Criminal Litigation
  • Copyright Infringement
  • COVID-19 Related Law
  • Criminal Matters
  • Cyber Law
  • Data Breach
  • Defamation
  • DMEPOS
  • DOJ
  • Drug Policy Law
  • Election Law
  • Employment Law
  • Environmental
  • False Claims Act
  • federal investigations
  • Federal Tax Investigations
  • FINRA
  • Firm Announcement
  • FOIS Compliance
  • Fraud Investigations
  • General
  • Government Affairs
  • Government Contract
  • Government Investigations
  • Government Litigation
  • Health Care
  • Health Care Fraud
  • Healthcare Transactions
  • Hemp & Cannabis
  • Hemp and Cannabis
  • HIPAA
  • Housing Development Law
  • Land Use Law
  • Land Zoning Law
  • Liquor Law
  • Medicare and Medicaid
  • Non-Profit Organizations
  • ommercial payor audits
  • Open Records Act
  • Overpayment Appeals
  • PPP Investigations
  • Public Corruption
  • Restrictive Covenants
  • SEC Investigations
  • Special Use Permit Filing
  • State Bar of Georgia Investigations
  • Strategic Land Use
  • Tax Fraud
  • toxic tort
  • Trade Law
  • Trademark Enforcement
  • Trademark Protection
  • Tree Ordinance
  • Uncategorized
  • Variances
  • White Collar Crime
  • Zoning and Land Use
Built by The Montgomery Group